Role of Helicobacter pylori infection in gastroduodenal damage in patients starting nsaid therapy: 4 months follow-up study

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2887-2892

  Sokic Milutinovic, Aleksandra ^a   Krstic, Miodrag ^a   Rozer Smolovic, Brigita ^b   Alempijevic, Tamara ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Clinical Center Podgorica   (Montenegro)

Author keywords

Erosion; Helicobacter pylori; NSAID; Ulcer

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CERVICAL SPINE INJURY; CONTROLLED STUDY; DUODENAL MUCOSA EROSION; DUODENUM DISEASE; DUODENUM ULCER; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC DISEASE; STOMACH EROSION; STOMACH MUCOSA; STOMACH MUCOSA INJURY; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT; AGED; BIOPSY; DRUG EFFECT; GASTRITIS; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; REGISTER; RISK FACTOR; TIME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RHEUMATIC DISEASES; RISK FACTORS; TIME FACTORS;

EID: 77957930222     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1097-5     Document Type: Article

References (28)

1. Hunt RH, Bazzoli F. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther. 2004;19(suppl 1):9-16.
2. Chan LK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications- review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004;19:1-11.
3. Graham DY. 'Guidelines' or marketing for non-steroidal antiinflammatory drug and proton pump inhibitor use? Aliment Pharmacol Ther. 2004;19:1323-1325.
4. Hawkey CJ. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis? Aliment Pharmacol Ther. 2004;20(suppl 2):59-64.
5. Lanas A. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract. Aliment Pharmacol Ther. 2004;20:1-11.
6. Huang JQ, Sridhar S, Hunt HR. Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in pepticulcer disease: a meta-analysis. Lancet. 2002;359:14-22.
7. Hawkey CJ, Tulassay Z, Szczepanski L, et al. Randomized controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet. 1998;352:1016-1021.
8. Chan FK, Sung JJ, Suen R, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcer? A prospective randomized study. Aliment Pharmacol Ther. 1998;12(12):1201-1205.
9. Labenz J, Blum AL, Bolten W, et al. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomized, double blind, placebo controlled, clinical trial. Gut. 2002;51:329-335.
10. Lazzaroni M, Bianchi Porro G. Review article: Helicobacter pylori and NSAID gastropathy. Aliment Pharmacol Ther. 2001;15(suppl 1):22-27.
11. Vergara M, Catalán M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther. 2005;21(12): 1411-1418.
12. Sung J. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Aliment Pharmacol Ther. 2004; 20(suppl 2):65-70.
13. Malfertheiner P, Megraud F, O' Morain CO, et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht consensus report. Eur J Gastroenterol Hepatol. 1997;9:91-92.
14. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol. 1996;20:1161-1181.
15. Lanza F, Peace K, Gustitus L, Rack MF, Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin induced gastric and duodenal ulceration. Am J Gastroenterol. 1988;83:143-146.
16. Seager JM, Hawkey CJ. Indigestion and non-steroidal antiinflammatory drags-ABC of the upper gastrointestinal tract. BMJ. 2001;323:1236-1239.
17. Halter F, Tarnawski AS, Schmassman A, Peskar BM. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut. 2001;49:443-453.
18. Cameron EA, Pratap JN, Sims TJ, et al. Three-year prospective validation of a pre-endoscopic risk stratification in patients with acute upper gastrointestinal hemorrhage. Eur J Gastroenterol Hepatol. 2002;14:497-501.
19. Hawkey CJ, Næsdal J, Wilson I, et al. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal antiinflammatory drugs. Gut. 2002;51:336-343.
20. VanLeerdam ME, Tytgat GNJ. Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther. 2002; 16(suppl 1):66-78.
21. Hawkey CJ, Wilson I, Nesdal J, Långström G, Swannell AJ, Yeomans ND. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut. 2002;51:344-350.
22. Okan A, Tankurt E, Aslan BU, Akpinar H, Simsek I, Gonen O. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: a case-control study. J Gastroenterol Hepatol. 2003;18:18-25.
23. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol. 1999;34: 234-237.
24. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a casecontrol study. Gastroenterology. 1999;116:1305-1309.
25. Lai KC, Lau CS, Ip WY, et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebocontrolled trial. Aliment Pharmacol Ther. 2003;17:799-805.
26. Laine L. The effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury. Aliment Pharmacol Ther. 2002;16(suppl 1):34-39.
27. Chan FK, To KF, Wu J, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomized trial. Lancet. 2002;359:9-13.
28. Chan FK, Sung JY, Chung SC, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997;350: 975-979.